Determinants of generic drug substitution in Switzerland.

TitreDeterminants of generic drug substitution in Switzerland.
Publication TypeJournal Article
Year of Publication2011
AuthorsDecollogny, A, Eggli, Y, Halfon, P, Lufkin, TM
JournalBMC Health Serv Res
Volume11
Pagination17
Date Published2011
DOI10.1186/1472-6963-11-17
ISSN1472-6963
Mots-clésDrug Prescriptions, Drug Substitution, Drugs, Generic, Female, Humans, Insurance Claim Reporting, Logistic Models, Male, Multivariate Analysis, Physician's Practice Patterns, Reimbursement Mechanisms, ROC Curve, Switzerland
Abstract

BACKGROUND: Since generic drugs have the same therapeutic effect as the original formulation but at generally lower costs, their use should be more heavily promoted. However, a considerable number of barriers to their wider use have been observed in many countries. The present study examines the influence of patients, physicians and certain characteristics of the generics' market on generic substitution in Switzerland.

METHODS: We used reimbursement claims' data submitted to a large health insurer by insured individuals living in one of Switzerland's three linguistic regions during 2003. All dispensed drugs studied here were substitutable. The outcome (use of a generic or not) was modelled by logistic regression, adjusted for patients' characteristics (gender, age, treatment complexity, substitution groups) and with several variables describing reimbursement incentives (deductible, co-payments) and the generics' market (prices, packaging, co-branded original, number of available generics, etc.).

RESULTS: The overall generics' substitution rate for 173,212 dispensed prescriptions was 31%, though this varied considerably across cantons. Poor health status (older patients, complex treatments) was associated with lower generic use. Higher rates were associated with higher out-of-pocket costs, greater price differences between the original and the generic, and with the number of generics on the market, while reformulation and repackaging were associated with lower rates. The substitution rate was 13% lower among hospital physicians. The adoption of the prescribing practices of the canton with the highest substitution rate would increase substitution in other cantons to as much as 26%.

CONCLUSIONS: Patient health status explained a part of the reluctance to substitute an original formulation by a generic. Economic incentives were efficient, but with a moderate global effect. The huge interregional differences indicated that prescribing behaviours and beliefs are probably the main determinant of generic substitution.

Alternate URL

http://www.ncbi.nlm.nih.gov/pubmed/21269426?dopt=Abstract

Alternate JournalBMC Health Serv Res
Citation Key / SERVAL ID2999
PubMed ID21269426
PubMed Central IDPMC3038892
                         

IUMSP | www.iumsp.ch
Institut universitaire de médecine sociale et préventive
Route de la Corniche 10, 1010 Lausanne - Switzerland
+41 21 314 72 72 | iumsp@chuv.ch

Go to top